Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
09/2005
09/29/2005WO2005090291A1 Ion channel modulators
09/29/2005WO2005055286A3 Zwitterionic compounds and photovoltaic cells containing same
09/29/2005WO2004084843A3 Inhibitors of cathepsin s
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215783 Thiourea compositions and uses thereof
09/29/2005US20050215637 Tuberculosis treatment
09/29/2005US20050215610 Such as 3-(4-(2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoylamino)-imidazol-1-yl)-butyric acid methyl ester; secretase, A beta -peptide inhibitor; neurogenerative and neurological diseases: Alzheimer's disease; Notch signaling pathway inhibitor; antiinflammatory agent, asthma, autoimmune diseases
09/29/2005US20050215609 Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist
09/29/2005US20050215573 Novel inhibitors of glutaminyl cyclase
09/29/2005US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
09/29/2005US20050211292 Zwitterionic compounds and photovoltaic cells containing same
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2557746A1 Ion channel modulators
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578898A2 Nad synthetase inhibitors and uses thereof
09/28/2005EP1233936B1 Process for preparing ambient temperature ionic liquids
09/28/2005EP0832071B1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
09/28/2005CN1675322A Printing process using specified azo compounds
09/28/2005CN1675230A Phosphonium and imidazolium salts and methods of their preparation
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/27/2005US6949658 Water solvent is substituted with a linear, branched, or cyclic alcohol having 3 or more carbon atoms; the acid is preferentially precipitated from the alcohol; addition of a base enables purification of the alpha amino amide
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases
09/27/2005US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis
09/27/2005US6949577 Drugs such as 5-amino-2-((1-n-propyl-1H-imidazol-4-yl)methyl) pentanoic acid, used as carboxypeptidase inhibitors for prophylaxis of thrombosis, atherosclerosis, adhesions, cancer, scarring, fibrosis and inflammation; bradykinins
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949536 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005US6949516 Oligopeptides used as antiapoptosis agents
09/27/2005CA2122346C Bistriazenes as chemotherapeutic agents
09/22/2005WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087751A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087748A1 Ion channel modulators
09/22/2005WO2005087747A1 Ion channel modulators
09/22/2005WO2005087743A1 Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors
09/22/2005WO2005087235A1 Pyrrolidine compounds
09/22/2005WO2005087229A1 Ion channel modulators
09/22/2005WO2005087228A1 Ion channel modulators
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005086895A2 Ion channel modulators
09/22/2005WO2005086892A2 Ion channel modulators
09/22/2005WO2005068445A3 Pesticidal heterocyclic dihaloallyl compounds
09/22/2005WO2004060376A8 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005DE102004010662A1 Verfahren zur Herstellung von Verbindungen mit quaternären sp2-hybridisierten Stickstoffatomen A process for the preparation of compounds with quaternary sp 2 -hybridized nitrogen atoms
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2558217A1 Ion channel modulators
09/22/2005CA2558214A1 Ion channel modulators
09/22/2005CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005CA2558034A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005CA2557672A1 Ion channel modulators
09/22/2005CA2557665A1 Ion channel modulators
09/22/2005CA2557648A1 Ion channel modulators
09/22/2005CA2557642A1 Ion channel modulators
09/22/2005CA2557637A1 Ion channel modulators
09/21/2005EP1576039A2 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents
09/21/2005EP1575923A2 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST &bgr;-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/21/2005EP1575538A1 Novel m- phenylendiamine derivatives as coupler components for the colouring of keratin fibres
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1339694B1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/21/2005EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
09/21/2005CN1671670A Novel imidazole alcohol compound, process for producing the same, and surface-treating agent comprising the same
09/21/2005CN1671654A Gelling agents
09/21/2005CN1671387A Aryl substituted hydantoin compounds and their use as sodium channel blockers
09/20/2005US6946492 Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005US6946298 Karl fischer reagent
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2231535C Imidazole derivatives having affinity for alpha2 receptors activity
09/15/2005WO2005085226A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
09/15/2005WO2005085209A1 Basic amine compound and use thereof
09/15/2005WO2005085208A1 2,4,5-triaryl substituted imidazole compound and 1,2,4,5-tetraaryl substituted imidazole compound
09/15/2005WO2005085207A2 Method for the production of ionic fluids the cation of which comprises a quaternary sp2 - hybridised nitrogen atom
09/15/2005WO2005085196A2 Inhibitors of dna methylation in tumor cells
09/15/2005WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers
09/15/2005WO2004099170A3 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
09/15/2005US20050203159 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
09/15/2005US20050203157 Long-lasting antimicrobial reaction product of allantoin and formaldehyde containing a low level of free formaldehyde
09/15/2005US20050203156 Hydantoins having RNase modulatory activity
09/15/2005US20050203155 Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections
09/15/2005US20050203143 Novel compounds as opioid receptor modulators
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005CA2558600A1 A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
09/15/2005CA2557581A1 Inhibitors of dna methylation in tumor cells
09/14/2005EP1574499A1 Inhibitors of DNA methylation in tumor cells
09/14/2005EP1574205A2 Composition comprising a chromophore of azo or tri(hetero)arymethane type
09/14/2005EP1572665A2 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors
09/14/2005EP1572662A1 Pyrazole and imidazole compounds and uses thereof
09/14/2005EP1572210A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/14/2005EP1572198A2 New pharmaceutical compounds
09/14/2005EP1572129A2 Amidine derivatives for treating amyloidosis
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 345